Angelini Ventures
Profile, fund size and portfolio
Angelini Ventures is the corporate venture arm of Angelini Industries, a conglomerate. It was founded in 2022 and is based in Rome, Italy. It invests from seed to Series B. Sectors it names: biotech and life sciences, healthcare and digital health, medical devices.
- Commitment by parentS3
- EUR 300M
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Series B |
| Sectors | Biotech and life sciences, Healthcare and digital health, Medical devices |
| Geography | North America, Europe |
| Offices | Rome, Italy |
Sources: S2 Angelini Ventures 2023 Sustainability Profile (PDF); S3 Angelini Industries press release: launch of Angelini Ventures (2022-10-19).
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | EUR 300M | Commitment by parent | Stated by the firm or its parent | S3 |
| Companies on the firm's portfolio page | 17 | companies | Counted from the firm's own list | S2 |
Sources: S3 Angelini Industries press release: launch of Angelini Ventures (2022-10-19); S2 Angelini Ventures 2023 Sustainability Profile (PDF).
Where it invests and who leads it
LeadersS1
- Paolo Di GiorgioCEO and Managing DirectorFind on LinkedInFirm page
- Elia StupkaManaging DirectorFind on LinkedInFirm page
- Tanja DoweManaging DirectorFind on LinkedInFirm page
- Regina HoditsManaging DirectorFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Angelini Industries | Single source | S3 |
| Parent industry | Conglomerate | Single source | S3 |
| Founded | 2022 | Single source | S3 |
| Headquarters | Rome, Italy | Single source | S3 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S3 |
| Headline size | EUR 300M (Commitment by parent) | Single source | S3 |
| People on the team page | 14 | Single source | S1 |
| Stages | Seed, Series A, Series B (inferred from announced rounds) | Estimate | S2 |
For founders
Portfolio
The firm's portfolio page lists 17 companies.S2
Every company on the Angelini Ventures list
17 companies, as listed on the firm's own website.S2 Read the firm's list.
- Arclight Therapeutics
- Argobio
- Avation Medical
- Cadence Neuroscience
- CoMind
- Congruence Therapeutics
- Cour Pharmaceuticals
- Damona Pharmaceuticals
- Epicrispr Biotechnologies
- Extend
- Freya Biosciences
- GenEp
- Handspring Health
- Noctrix Health
- Nouscom
- Pretzel Therapeutics
- Serenis
Fund vehicles
| Vehicle | Size | Year | Source |
|---|---|---|---|
| Angelini Lumira Biosciences Fund | USD 35M | 2021 | S2 |
Recent rounds
Official pages
Read the firm's own pages for current information.
Sources
- S1Angelini Ventures home pageFirm
- S2Angelini Ventures 2023 Sustainability Profile (PDF)Firm
- S3Angelini Industries press release: launch of Angelini Ventures (2022-10-19)Parent company
- S4Angelini Ventures news: Epicrispr Series C (2026-08-10)Firm
- S5Angelini Ventures news: Handspring Health Series B (2026-07-08)Firm
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Angelini Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.